Answers are grounded in this paper and cite their sources.
Extract A much-needed consensus statement on quality standards for managing children and adolescents with bronchiectasis was recently published by the Child-BEAR-Net, a Clinical Research Collaboration funded by the European Respiratory Society [1]. These quality standards were reached using Delphi methodology. The responses came from 54 countries from both clinicians and children with bronchiectasis and their parents, making it a truly international consensus. There were 7 quality standards (QS) agreed: (1) any suspected cases should have bronchiectasis confirmed by a chest CT, (2) appropriate airway clearance techniques are taught by a respiratory physiotherapist, (3) acute exacerbations are prescribed at least 14 days of antibiotics, (4) any having more than one hospitalised or greater than or equal to three non-hospitalised exacerbations in one year are offered a 6-month trial of macrolide antibiotics and response assessed, (5) a minimum panel of diagnostic tests are undertaken, (6) care is received from a specialist paediatric respiratory physician and (7) review is at least 6-monthly by a multidisciplinary team (MDT).
No takes yet. Share an insight, caveat, or question.
Carr et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: